Pacific Biosciences (NASDAQ:PACB) reported its Q4 earnings results on Tuesday, February 15, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Pacific Biosciences missed estimated earnings by 7.14%, reporting an EPS of $-0.3 versus an estimate of $-0.28.
Revenue was up $8.88 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.01, which was followed by a 5.55% increase in the share price the next day.
Here's a look at Pacific Biosciences's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.22 | -0.20 | -0.45 | 0.32 |
| EPS Actual | -0.23 | -0.21 | -0.45 | 0.37 |
| Revenue Estimate | 33.23M | 29.89M | 25.67M | 25.41M |
| Revenue Actual | 34.89M | 30.61M | 29.00M | 27.14M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
